NCT03726203

Brief Summary

During laparoscopy, trocars are essential: they allow the passage of instruments through the wall. In gynecology, with exception, trocars 5mm (used for the passage of endo-scissors and forceps) and 10 to 12mm are used (especially for optics). Trocars are responsible for complications, such as vascular wounds, digestive wounds, pain, infections or postoperative hernias, or aesthetic sequelae, and should be chosen with caution: most complications of laparoscopy are essentially due to their placement, and the complications at the introduction of the first trocar are the most frequent. The MiniLap® system developed by Teleflex does not require trocars in the case of a single forceps, or a single 5mm trocar with the necessary forceps change (this is the Percuvance® system). The aim of the latter is to make minimally invasive surgery even less invasive, thanks to a reduction in the number of trocars used (in many cases, elimination of two trocars), smaller incisions (percutaneous use of instruments, with a diameter of 2,4mm) thus reducing the complications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 31, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

January 15, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2021

Completed
Last Updated

April 29, 2021

Status Verified

April 1, 2021

Enrollment Period

2.3 years

First QC Date

October 29, 2018

Last Update Submit

April 28, 2021

Conditions

Keywords

LaparoscopyTrocarMiniLapsurgerygynecologypain, scarsscars

Outcome Measures

Primary Outcomes (1)

  • The time required to validate the Marshall and Chung criteria authorizing outpatient discharge when using the Minilap® system in comparison to the use of conventional trocars.

    at the end of surgery, an average 3 hours

Secondary Outcomes (5)

  • Pain using the Visual Analog Scale (VAS)

    at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).

  • Aesthetic scars using a scale of 0 to 10

    postoperative visit (6 weeks ± 1 after surgery).

  • number of complication per operative

    At immediate postoperative (baseline,1 hour and 3 hours)

  • of the intraoperative use of the trocar system using a questionnaire to be completed by the surgeon

    At immediate postoperative (baseline,1 hour and 3 hours)

  • post-operative complications at the level of the trocar apertures using a questionnaire

    at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).

Study Arms (2)

trocars of type MiniLap

EXPERIMENTAL

Patients benefiting from the use of trocars of type MiniLap of Teleflex during the realization of their coelioscopy scheduled in ambulatory

Device: laparoscopic gynecologic surgery with the MiniLap System.

trocars classics

ACTIVE COMPARATOR

Patients benefiting from the use of trocats classics during the realization of their coelioscopy scheduled(programmed) in ambulatory.

Device: laparoscopic gynecologic surgery with the conventional single-use trocars.

Interventions

Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care, but using the MiniLap System instead of the conventional single-use trocars used usually.

trocars of type MiniLap

Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care using the conventional single-use trocars used usually.

trocars classics

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI \<35kg / m2
  • No history of multiple abdominopelvic surgery
  • Without absolute contraindication to laparoscopy
  • In the context of ambulatory surgery
  • With precise laparoscopy of indication:
  • Exploratory or diagnostic
  • Exploration of infertility
  • Performing a tubal permeability test
  • Performing a salpingectomy
  • Realization of a tubal sterilization
  • Realization of a tubal plasty
  • Performing an ovariectomy
  • Performing a simple ovarian cystectomy
  • Patient have been informed during her preoperative consultation and have signed the consent in a free and informed manner upon admission to hospital

You may not qualify if:

  • Performing an emergency surgery
  • Carcinological surgery
  • Performing a benign but complex surgery such as:
  • Hysterectomy
  • Prolapse cure
  • promontofixation
  • Complex surgery of endometriosis
  • Removal of large cyst from the ovary.
  • Person unable to receive informed information and / or give consent. Person deprived of liberty.
  • Pregnant or nursing woman.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Jeanne de Flandres, CHU

Lille, France

Location

MeSH Terms

Conditions

PainCicatrix

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsFibrosisPathologic Processes

Study Officials

  • Chrystelle Rubod, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2018

First Posted

October 31, 2018

Study Start

January 15, 2019

Primary Completion

April 27, 2021

Study Completion

April 27, 2021

Last Updated

April 29, 2021

Record last verified: 2021-04

Locations